HSIE Results Daily: Lupin, Hitachi Energy, Berger Paints, Apollo Tyres
Lupin: EBITDA was up 30% YoY, led by 11% YoY sales growth (US: +4% QoQ, India +7% YoY) and higher GM (+197 bps YoY), which was partly offset by...
489 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an âExecutive Orderâ (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
216 Views
Pharmaceuticals: Lupin/Zydus lost Myrbetriq patent case in district court
Lupin and Zydus received unfavourable opinion in Mirabegron (gMyrbetriq) patent litigation (against Astellas Pharma) from the District court of...
771 Views
Q4FY25 Earnings Preview - Pharma & Healthcare
Moreover, adjusted PAT is expected to grow by 8.7% YoY and decrease by 7.9% QoQ. Domestic formulations and niche launches in the US market will...
270 Views
Pharmaceuticals: Pharma dodges first round of US tariff risk
The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India
261 Views